data_1jc8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jc8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.183 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.259 24.5 pt -97.14 -57.83 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 124.264 0.978 . . . . 0.0 111.729 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -77.51 -52.89 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.84 -93.55 1.91 Allowed Glycine 0 CA--C 1.541 1.702 0 CA-C-N 118.858 0.753 . . . . 0.0 112.702 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -146.27 171.51 14.86 Favored 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 123.458 0.703 . . . . 0.0 110.83 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t -79.13 -58.88 3.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.488 -1.383 . . . . 0.0 114.023 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.76 65.95 1.24 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-N 119.034 0.833 . . . . 0.0 113.999 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -157.92 -71.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.17 -77.57 0.45 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.0 tp -97.05 127.08 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.74 0.781 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.2 m -139.14 86.35 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 124.303 2.001 . . . . 0.0 110.168 -179.647 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.2 pt -99.38 -54.47 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 124.535 1.147 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -72.96 -51.39 18.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.25 -121.16 3.08 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 118.699 0.682 . . . . 0.0 112.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.62 161.63 14.84 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 122.868 0.467 . . . . 0.0 111.3 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -69.26 -50.36 47.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.4 56.22 2.44 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -159.0 -69.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.661 0.784 . . . . 0.0 108.925 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.88 -74.38 0.31 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 tp -87.9 115.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.597 0.759 . . . . 0.0 109.281 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.957 0.884 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.3 m -154.62 104.53 2.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.216 1.96 . . . . 0.0 110.973 -179.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.1 pt -127.55 -43.61 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 124.478 1.111 . . . . 0.0 113.811 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -76.6 -58.03 3.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.63 -107.04 1.34 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.97 166.01 12.59 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 122.818 0.447 . . . . 0.0 111.083 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -81.29 -67.81 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.523 -1.36 . . . . 0.0 112.454 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 -48.94 0.89 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -72.38 -59.58 2.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.14 -71.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.248 0.931 . . . . 0.0 111.002 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tp -78.91 104.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 119.042 0.837 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 m -96.74 86.71 4.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 124.016 1.865 . . . . 0.0 110.66 -179.179 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 pt -127.77 -53.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 124.42 1.075 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -82.32 -59.55 2.51 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.421 1.009 . . . . 0.0 113.056 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.97 -88.34 0.18 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.75 167.43 18.17 Favored 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 t -72.63 -52.74 14.12 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.25 57.32 2.02 Favored Glycine 0 CA--C 1.546 1.989 0 CA-C-N 118.948 0.795 . . . . 0.0 114.855 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -160.4 -69.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -142.26 -73.34 0.31 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -89.95 117.97 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 0.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.5 m -96.3 83.52 3.59 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.373 2.035 . . . . 0.0 110.609 -179.678 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.274 17.1 pt -98.3 -66.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.165 0.915 . . . . 0.0 110.643 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -75.22 -55.74 5.42 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.317 0.962 . . . . 0.0 112.692 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.71 87.58 0.87 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -114.65 162.77 16.35 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.538 0.735 . . . . 0.0 111.679 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -77.72 -61.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.642 -1.286 . . . . 0.0 113.044 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.26 65.15 0.81 Allowed Glycine 0 N--CA 1.484 1.891 0 CA-C-N 119.074 0.852 . . . . 0.0 114.753 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -161.12 -73.11 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.8 tp -138.85 -73.04 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.2 117.17 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.5 m -142.39 98.88 3.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 122.854 1.312 . . . . 0.0 109.746 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.81 -53.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 124.248 0.968 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -84.02 -58.89 2.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.25 -87.77 0.99 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.69 158.92 44.48 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 123.355 0.662 . . . . 0.0 109.735 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -74.78 -53.8 8.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.423 -1.423 . . . . 0.0 114.625 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.01 57.59 1.68 Allowed Glycine 0 CA--C 1.546 1.988 0 CA-C-N 119.037 0.835 . . . . 0.0 114.915 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -159.62 -75.78 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.4 mt -133.56 -73.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.4 tp -89.79 114.71 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.669 0.787 . . . . 0.0 109.353 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.571 1.776 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -145.51 80.33 1.59 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 124.378 2.037 . . . . 0.0 110.497 -179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.26 17.8 pt -82.06 -61.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 123.898 0.749 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -77.87 -51.66 10.09 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.712 0.805 . . . . 0.0 112.501 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.36 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.537 1.424 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -149.39 156.49 42.12 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.358 0.663 . . . . 0.0 109.396 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -74.53 -52.11 12.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.405 -1.435 . . . . 0.0 114.778 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.6 55.68 2.0 Favored Glycine 0 CA--C 1.546 1.994 0 CA-C-N 119.037 0.835 . . . . 0.0 114.854 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -159.92 -75.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.92 -71.93 0.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -88.68 112.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 119.013 0.824 . . . . 0.0 109.82 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 6.3 t . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.7 m -96.51 85.65 3.95 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.157 1.932 . . . . 0.0 109.741 -179.453 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.79 -52.51 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 124.196 0.935 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -78.9 -53.68 6.82 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.776 0.83 . . . . 0.0 112.898 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.72 -100.8 0.14 Allowed Glycine 0 N--CA 1.479 1.521 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -139.13 159.47 42.07 Favored 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 123.302 0.641 . . . . 0.0 110.193 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.2 m -78.13 -61.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.463 -1.398 . . . . 0.0 113.198 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.12 -46.06 1.1 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 115.816 1.087 . . . . 0.0 115.816 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -77.0 -65.53 0.94 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -137.37 -69.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.38 0.991 . . . . 0.0 112.334 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -79.62 99.15 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 119.361 0.982 . . . . 0.0 112.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.579 2.082 0 N-CA-C 118.583 2.809 . . . . 0.0 118.583 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 m -125.29 84.59 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 124.251 1.977 . . . . 0.0 109.061 -178.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.25 47.4 pt -119.72 -47.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 124.286 0.991 . . . . 0.0 112.616 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.22 -57.79 3.64 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 119.382 0.992 . . . . 0.0 113.056 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.25 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.68 160.87 41.06 Favored 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 123.138 0.575 . . . . 0.0 110.365 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -73.1 -50.98 19.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 55.44 2.16 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -160.16 -76.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -134.75 -72.79 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 tp -86.87 113.58 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.945 0.793 . . . . 0.0 109.415 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.3 m -143.38 83.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 124.363 2.03 . . . . 0.0 110.111 -179.545 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.02 -49.58 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 124.209 0.943 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.63 -57.19 4.97 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.394 0.997 . . . . 0.0 112.196 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.4 -95.19 0.76 Allowed Glycine 0 CA--C 1.543 1.793 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -160.32 156.99 27.19 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 117.756 0.778 . . . . 0.0 111.159 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.8 m -81.57 -59.37 2.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.639 -1.288 . . . . 0.0 113.374 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.13 59.85 0.8 Allowed Glycine 0 CA--C 1.545 1.946 0 CA-C-N 118.99 0.814 . . . . 0.0 114.19 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -161.33 -70.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.4 tp -140.83 -72.86 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -85.01 117.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 m -152.16 109.8 3.62 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 124.13 1.919 . . . . 0.0 111.977 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 16.7 pt -140.68 -58.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.065 0.853 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -90.39 -64.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.289 0.949 . . . . 0.0 112.218 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.07 -104.29 1.18 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.097 0.862 . . . . 0.0 112.006 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.4 158.09 42.17 Favored 'General case' 0 CA--C 1.575 1.931 0 CA-C-N 117.314 0.557 . . . . 0.0 111.294 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -84.69 -61.62 1.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.155 . . . . 0.0 112.982 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.19 60.37 0.68 Allowed Glycine 0 CA--C 1.545 1.945 0 CA-C-N 119.201 0.909 . . . . 0.0 114.077 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -161.44 -70.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -138.62 -74.32 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -85.61 116.53 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.256 6.0 t . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -147.0 83.5 1.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 124.109 1.909 . . . . 0.0 108.334 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.259 19.0 pt -130.72 -59.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 124.225 0.953 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -84.2 -65.93 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.359 0.982 . . . . 0.0 111.641 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.66 -95.57 1.71 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.985 0.811 . . . . 0.0 112.849 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.99 162.66 22.57 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 122.919 0.488 . . . . 0.0 111.1 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.8 m -70.56 -47.83 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.26 50.09 4.44 Favored Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.79 -75.12 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.75 -72.92 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.548 0.739 . . . . 0.0 109.239 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -87.24 108.76 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 119.208 0.913 . . . . 0.0 110.204 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.252 6.6 t . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.0 m -101.5 84.32 2.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 124.248 1.975 . . . . 0.0 109.972 -178.767 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -83.44 -56.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.013 0.821 . . . . 0.0 111.009 . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -65.45 -47.67 75.33 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.67 -97.24 0.14 Allowed Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -141.08 155.21 46.17 Favored 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 123.263 0.625 . . . . 0.0 109.627 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t -78.7 -64.51 1.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.53 -1.356 . . . . 0.0 113.292 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.23 -41.34 1.75 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 116.217 1.247 . . . . 0.0 116.217 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -72.06 -54.89 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.2 tp -143.86 -77.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.44 1.018 . . . . 0.0 110.524 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -86.05 120.77 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 119.05 0.841 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 6.2 t . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 119.216 3.043 . . . . 0.0 119.216 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.1 m -100.88 88.66 3.61 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 124.02 1.867 . . . . 0.0 109.975 -178.416 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.304 0.0 OUTLIER -141.87 -71.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 124.132 0.895 . . . . 0.0 109.1 . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.21 -55.01 5.22 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.15 -92.73 1.77 Allowed Glycine 0 N--CA 1.481 1.646 0 CA-C-N 118.718 0.69 . . . . 0.0 112.499 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -148.41 166.08 29.18 Favored 'General case' 0 CA--C 1.578 2.022 0 C-N-CA 123.376 0.67 . . . . 0.0 110.766 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 t -73.01 -42.14 63.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 45.88 7.61 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.52 -65.69 0.32 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.94 0.896 . . . . 0.0 108.751 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 tp -152.6 -69.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.0 106.24 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.5 m -106.34 79.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 124.108 1.909 . . . . 0.0 108.853 -179.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.258 22.8 pt -125.56 -57.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 124.271 0.982 . . . . 0.0 111.696 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.79 -61.56 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.56 1.073 . . . . 0.0 113.576 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.63 -91.9 1.77 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -154.33 157.16 38.2 Favored 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 123.264 0.626 . . . . 0.0 109.856 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -80.0 -58.96 2.91 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 120.611 -1.306 . . . . 0.0 114.111 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.7 57.66 1.09 Allowed Glycine 0 CA--C 1.546 2.028 0 CA-C-N 118.608 0.64 . . . . 0.0 113.785 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -159.6 -70.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -139.79 -73.76 0.36 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.95 116.03 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.6 t . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -151.59 93.44 1.87 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.461 1.028 . . . . 0.0 110.973 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 124.142 1.925 . . . . 0.0 109.067 179.157 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.232 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.256 21.6 pt -129.01 -57.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 124.252 0.97 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -82.51 -65.62 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 119.487 1.039 . . . . 0.0 112.828 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.45 -93.49 1.73 Allowed Glycine 0 CA--C 1.543 1.788 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -154.7 160.15 41.18 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.436 0.694 . . . . 0.0 109.973 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 t -75.32 -50.73 15.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.08 53.04 2.92 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-N 118.888 0.767 . . . . 0.0 114.249 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -159.9 -68.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.904 0.882 . . . . 0.0 108.772 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.99 -73.95 0.31 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.511 0.724 . . . . 0.0 109.451 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.69 109.74 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.263 5.6 t . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -155.72 106.39 2.48 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.829 1.195 . . . . 0.0 110.249 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 124.091 1.9 . . . . 0.0 108.652 179.259 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.278 0.2 OUTLIER -130.75 -54.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 124.287 0.992 . . . . 0.0 111.933 . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -82.29 -63.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 119.812 1.187 . . . . 0.0 112.207 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.41 -94.33 1.7 Allowed Glycine 0 N--CA 1.482 1.706 0 CA-C-N 118.992 0.814 . . . . 0.0 113.459 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.55 163.58 20.32 Favored 'General case' 0 CA--C 1.577 2.019 0 C-N-CA 123.161 0.584 . . . . 0.0 111.964 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 t -70.58 -50.05 41.33 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.65 56.38 3.37 Favored Glycine 0 CA--C 1.546 2.004 0 CA-C-N 118.969 0.804 . . . . 0.0 114.71 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -158.9 -63.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.691 0.796 . . . . 0.0 109.729 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.299 0.4 OUTLIER -142.32 -74.02 0.3 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.638 0.775 . . . . 0.0 110.025 179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -100.06 116.61 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.25 5.7 t . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 120.658 3.577 . . . . 0.0 120.658 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 t -144.32 109.22 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.132 1.92 . . . . 0.0 111.71 -179.858 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.268 0.2 OUTLIER -126.94 -50.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 124.329 1.018 . . . . 0.0 112.601 . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -77.82 -56.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 120.026 1.284 . . . . 0.0 114.105 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.12 -87.55 1.56 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.033 0.833 . . . . 0.0 112.153 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.2 165.07 28.88 Favored 'General case' 0 CA--C 1.576 1.966 0 C-N-CA 123.629 0.772 . . . . 0.0 110.162 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -75.37 -51.67 12.59 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.17 54.44 2.86 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-N 118.856 0.753 . . . . 0.0 114.173 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.69 -67.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.826 0.85 . . . . 0.0 109.208 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.28 2.4 pt? -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.567 0.747 . . . . 0.0 112.208 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.35 109.27 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.268 6.0 t . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 120.933 3.679 . . . . 0.0 120.933 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 t -152.91 108.28 3.26 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.525 1.057 . . . . 0.0 110.445 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 124.094 1.902 . . . . 0.0 108.442 179.427 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.307 20.4 tt -145.9 -80.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -65.22 -46.14 81.84 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.78 -87.02 0.08 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.97 171.89 12.57 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 123.024 0.529 . . . . 0.0 110.43 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t -72.21 -50.16 29.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.073 -1.642 . . . . 0.0 114.444 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.55 59.23 1.65 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 118.875 0.761 . . . . 0.0 114.442 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -160.45 -71.9 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.6 tp -148.02 -69.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.809 0.844 . . . . 0.0 108.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 103.31 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 122.173 0.987 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.2 p -147.31 100.71 3.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 124.115 1.912 . . . . 0.0 111.562 -179.59 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.292 20.1 tt -147.96 -77.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -61.27 -47.28 86.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.59 -103.09 0.17 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.85 148.02 27.96 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 t -70.58 -50.75 34.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.74 57.25 1.54 Allowed Glycine 0 N--CA 1.485 1.929 0 CA-C-N 119.179 0.899 . . . . 0.0 114.527 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -161.22 -69.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.8 tp -144.23 -67.96 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 0.0 109.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.32 106.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.661 0.784 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 122.306 1.05 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.6 p -96.52 83.61 3.54 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.639 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.153 1.93 . . . . 0.0 111.156 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.183 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.259 24.5 pt -97.14 -57.83 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 124.264 0.978 . . . . 0.0 111.729 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -77.51 -52.89 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.84 -93.55 1.91 Allowed Glycine 0 CA--C 1.541 1.702 0 CA-C-N 118.858 0.753 . . . . 0.0 112.702 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -146.27 171.51 14.86 Favored 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 123.458 0.703 . . . . 0.0 110.83 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t -79.13 -58.88 3.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.488 -1.383 . . . . 0.0 114.023 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.76 65.95 1.24 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-N 119.034 0.833 . . . . 0.0 113.999 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -157.92 -71.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.17 -77.57 0.45 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.0 tp -97.05 127.08 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.74 0.781 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.2 m -139.14 86.35 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 124.303 2.001 . . . . 0.0 110.168 -179.647 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.2 pt -99.38 -54.47 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 124.535 1.147 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -72.96 -51.39 18.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.25 -121.16 3.08 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 118.699 0.682 . . . . 0.0 112.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.62 161.63 14.84 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 122.868 0.467 . . . . 0.0 111.3 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -69.26 -50.36 47.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.4 56.22 2.44 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -159.0 -69.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.661 0.784 . . . . 0.0 108.925 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.88 -74.38 0.31 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 tp -87.9 115.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.597 0.759 . . . . 0.0 109.281 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.957 0.884 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.3 m -154.62 104.53 2.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.216 1.96 . . . . 0.0 110.973 -179.889 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.1 pt -127.55 -43.61 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 124.478 1.111 . . . . 0.0 113.811 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -76.6 -58.03 3.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.63 -107.04 1.34 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.97 166.01 12.59 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 122.818 0.447 . . . . 0.0 111.083 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -81.29 -67.81 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.523 -1.36 . . . . 0.0 112.454 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 -48.94 0.89 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -72.38 -59.58 2.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.14 -71.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.248 0.931 . . . . 0.0 111.002 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tp -78.91 104.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 119.042 0.837 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 m -96.74 86.71 4.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 124.016 1.865 . . . . 0.0 110.66 -179.179 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 pt -127.77 -53.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 124.42 1.075 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -82.32 -59.55 2.51 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.421 1.009 . . . . 0.0 113.056 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.97 -88.34 0.18 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.75 167.43 18.17 Favored 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 t -72.63 -52.74 14.12 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.25 57.32 2.02 Favored Glycine 0 CA--C 1.546 1.989 0 CA-C-N 118.948 0.795 . . . . 0.0 114.855 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -160.4 -69.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -142.26 -73.34 0.31 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -89.95 117.97 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 0.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.5 m -96.3 83.52 3.59 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.373 2.035 . . . . 0.0 110.609 -179.678 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.274 17.1 pt -98.3 -66.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.165 0.915 . . . . 0.0 110.643 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -75.22 -55.74 5.42 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.317 0.962 . . . . 0.0 112.692 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.71 87.58 0.87 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -114.65 162.77 16.35 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.538 0.735 . . . . 0.0 111.679 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -77.72 -61.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.642 -1.286 . . . . 0.0 113.044 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.26 65.15 0.81 Allowed Glycine 0 N--CA 1.484 1.891 0 CA-C-N 119.074 0.852 . . . . 0.0 114.753 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -161.12 -73.11 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.8 tp -138.85 -73.04 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.2 117.17 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.5 m -142.39 98.88 3.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 122.854 1.312 . . . . 0.0 109.746 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.81 -53.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 124.248 0.968 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -84.02 -58.89 2.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.25 -87.77 0.99 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.69 158.92 44.48 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 123.355 0.662 . . . . 0.0 109.735 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -74.78 -53.8 8.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.423 -1.423 . . . . 0.0 114.625 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.01 57.59 1.68 Allowed Glycine 0 CA--C 1.546 1.988 0 CA-C-N 119.037 0.835 . . . . 0.0 114.915 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -159.62 -75.78 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.4 mt -133.56 -73.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.4 tp -89.79 114.71 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.669 0.787 . . . . 0.0 109.353 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.571 1.776 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -145.51 80.33 1.59 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 124.378 2.037 . . . . 0.0 110.497 -179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.26 17.8 pt -82.06 -61.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 123.898 0.749 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -77.87 -51.66 10.09 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.712 0.805 . . . . 0.0 112.501 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.36 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.537 1.424 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -149.39 156.49 42.12 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.358 0.663 . . . . 0.0 109.396 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -74.53 -52.11 12.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.405 -1.435 . . . . 0.0 114.778 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.6 55.68 2.0 Favored Glycine 0 CA--C 1.546 1.994 0 CA-C-N 119.037 0.835 . . . . 0.0 114.854 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -159.92 -75.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.92 -71.93 0.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -88.68 112.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 119.013 0.824 . . . . 0.0 109.82 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 6.3 t . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.7 m -96.51 85.65 3.95 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.157 1.932 . . . . 0.0 109.741 -179.453 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.79 -52.51 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 124.196 0.935 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -78.9 -53.68 6.82 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.776 0.83 . . . . 0.0 112.898 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.72 -100.8 0.14 Allowed Glycine 0 N--CA 1.479 1.521 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -139.13 159.47 42.07 Favored 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 123.302 0.641 . . . . 0.0 110.193 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.2 m -78.13 -61.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.463 -1.398 . . . . 0.0 113.198 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.12 -46.06 1.1 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 115.816 1.087 . . . . 0.0 115.816 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -77.0 -65.53 0.94 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -137.37 -69.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.38 0.991 . . . . 0.0 112.334 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -79.62 99.15 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 119.361 0.982 . . . . 0.0 112.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.579 2.082 0 N-CA-C 118.583 2.809 . . . . 0.0 118.583 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 m -125.29 84.59 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 124.251 1.977 . . . . 0.0 109.061 -178.926 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.25 47.4 pt -119.72 -47.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 124.286 0.991 . . . . 0.0 112.616 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.22 -57.79 3.64 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 119.382 0.992 . . . . 0.0 113.056 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.25 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.68 160.87 41.06 Favored 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 123.138 0.575 . . . . 0.0 110.365 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -73.1 -50.98 19.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 55.44 2.16 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -160.16 -76.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -134.75 -72.79 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 tp -86.87 113.58 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.945 0.793 . . . . 0.0 109.415 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.3 m -143.38 83.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 124.363 2.03 . . . . 0.0 110.111 -179.545 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.02 -49.58 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 124.209 0.943 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.63 -57.19 4.97 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.394 0.997 . . . . 0.0 112.196 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.4 -95.19 0.76 Allowed Glycine 0 CA--C 1.543 1.793 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -160.32 156.99 27.19 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 117.756 0.778 . . . . 0.0 111.159 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.8 m -81.57 -59.37 2.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.639 -1.288 . . . . 0.0 113.374 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.13 59.85 0.8 Allowed Glycine 0 CA--C 1.545 1.946 0 CA-C-N 118.99 0.814 . . . . 0.0 114.19 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -161.33 -70.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.4 tp -140.83 -72.86 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -85.01 117.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 m -152.16 109.8 3.62 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 124.13 1.919 . . . . 0.0 111.977 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 16.7 pt -140.68 -58.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.065 0.853 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -90.39 -64.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.289 0.949 . . . . 0.0 112.218 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.07 -104.29 1.18 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.097 0.862 . . . . 0.0 112.006 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.4 158.09 42.17 Favored 'General case' 0 CA--C 1.575 1.931 0 CA-C-N 117.314 0.557 . . . . 0.0 111.294 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -84.69 -61.62 1.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.155 . . . . 0.0 112.982 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.19 60.37 0.68 Allowed Glycine 0 CA--C 1.545 1.945 0 CA-C-N 119.201 0.909 . . . . 0.0 114.077 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -161.44 -70.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -138.62 -74.32 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -85.61 116.53 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.256 6.0 t . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -147.0 83.5 1.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 124.109 1.909 . . . . 0.0 108.334 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.259 19.0 pt -130.72 -59.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 124.225 0.953 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -84.2 -65.93 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.359 0.982 . . . . 0.0 111.641 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.66 -95.57 1.71 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.985 0.811 . . . . 0.0 112.849 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.99 162.66 22.57 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 122.919 0.488 . . . . 0.0 111.1 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.8 m -70.56 -47.83 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.26 50.09 4.44 Favored Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.79 -75.12 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.75 -72.92 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.548 0.739 . . . . 0.0 109.239 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -87.24 108.76 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 119.208 0.913 . . . . 0.0 110.204 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.252 6.6 t . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.0 m -101.5 84.32 2.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 124.248 1.975 . . . . 0.0 109.972 -178.767 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -83.44 -56.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.013 0.821 . . . . 0.0 111.009 . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -65.45 -47.67 75.33 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.67 -97.24 0.14 Allowed Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -141.08 155.21 46.17 Favored 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 123.263 0.625 . . . . 0.0 109.627 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t -78.7 -64.51 1.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.53 -1.356 . . . . 0.0 113.292 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.23 -41.34 1.75 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 116.217 1.247 . . . . 0.0 116.217 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -72.06 -54.89 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.2 tp -143.86 -77.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.44 1.018 . . . . 0.0 110.524 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -86.05 120.77 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 119.05 0.841 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 6.2 t . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 119.216 3.043 . . . . 0.0 119.216 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.1 m -100.88 88.66 3.61 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 124.02 1.867 . . . . 0.0 109.975 -178.416 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.304 0.0 OUTLIER -141.87 -71.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 124.132 0.895 . . . . 0.0 109.1 . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.21 -55.01 5.22 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.15 -92.73 1.77 Allowed Glycine 0 N--CA 1.481 1.646 0 CA-C-N 118.718 0.69 . . . . 0.0 112.499 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -148.41 166.08 29.18 Favored 'General case' 0 CA--C 1.578 2.022 0 C-N-CA 123.376 0.67 . . . . 0.0 110.766 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 t -73.01 -42.14 63.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 45.88 7.61 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.52 -65.69 0.32 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.94 0.896 . . . . 0.0 108.751 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 tp -152.6 -69.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.0 106.24 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.5 m -106.34 79.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 124.108 1.909 . . . . 0.0 108.853 -179.657 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.258 22.8 pt -125.56 -57.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 124.271 0.982 . . . . 0.0 111.696 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.79 -61.56 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.56 1.073 . . . . 0.0 113.576 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.63 -91.9 1.77 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -154.33 157.16 38.2 Favored 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 123.264 0.626 . . . . 0.0 109.856 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -80.0 -58.96 2.91 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 120.611 -1.306 . . . . 0.0 114.111 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.7 57.66 1.09 Allowed Glycine 0 CA--C 1.546 2.028 0 CA-C-N 118.608 0.64 . . . . 0.0 113.785 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -159.6 -70.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -139.79 -73.76 0.36 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.95 116.03 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.6 t . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -151.59 93.44 1.87 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.461 1.028 . . . . 0.0 110.973 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 124.142 1.925 . . . . 0.0 109.067 179.157 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.232 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.256 21.6 pt -129.01 -57.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 124.252 0.97 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -82.51 -65.62 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 119.487 1.039 . . . . 0.0 112.828 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.45 -93.49 1.73 Allowed Glycine 0 CA--C 1.543 1.788 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -154.7 160.15 41.18 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.436 0.694 . . . . 0.0 109.973 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 t -75.32 -50.73 15.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.08 53.04 2.92 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-N 118.888 0.767 . . . . 0.0 114.249 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -159.9 -68.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.904 0.882 . . . . 0.0 108.772 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.99 -73.95 0.31 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.511 0.724 . . . . 0.0 109.451 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.69 109.74 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.263 5.6 t . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -155.72 106.39 2.48 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.829 1.195 . . . . 0.0 110.249 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 124.091 1.9 . . . . 0.0 108.652 179.259 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.278 0.2 OUTLIER -130.75 -54.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 124.287 0.992 . . . . 0.0 111.933 . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -82.29 -63.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 119.812 1.187 . . . . 0.0 112.207 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.41 -94.33 1.7 Allowed Glycine 0 N--CA 1.482 1.706 0 CA-C-N 118.992 0.814 . . . . 0.0 113.459 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.55 163.58 20.32 Favored 'General case' 0 CA--C 1.577 2.019 0 C-N-CA 123.161 0.584 . . . . 0.0 111.964 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 t -70.58 -50.05 41.33 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.65 56.38 3.37 Favored Glycine 0 CA--C 1.546 2.004 0 CA-C-N 118.969 0.804 . . . . 0.0 114.71 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -158.9 -63.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.691 0.796 . . . . 0.0 109.729 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 10' ' ' ILE 0.299 0.4 OUTLIER -142.32 -74.02 0.3 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.638 0.775 . . . . 0.0 110.025 179.673 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -100.06 116.61 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.25 5.7 t . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 120.658 3.577 . . . . 0.0 120.658 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 t -144.32 109.22 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.132 1.92 . . . . 0.0 111.71 -179.858 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.268 0.2 OUTLIER -126.94 -50.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 124.329 1.018 . . . . 0.0 112.601 . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -77.82 -56.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 120.026 1.284 . . . . 0.0 114.105 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.12 -87.55 1.56 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.033 0.833 . . . . 0.0 112.153 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.2 165.07 28.88 Favored 'General case' 0 CA--C 1.576 1.966 0 C-N-CA 123.629 0.772 . . . . 0.0 110.162 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -75.37 -51.67 12.59 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.17 54.44 2.86 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-N 118.856 0.753 . . . . 0.0 114.173 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.69 -67.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.826 0.85 . . . . 0.0 109.208 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.28 2.4 pt? -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.567 0.747 . . . . 0.0 112.208 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.35 109.27 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.268 6.0 t . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 120.933 3.679 . . . . 0.0 120.933 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 t -152.91 108.28 3.26 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.525 1.057 . . . . 0.0 110.445 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 124.094 1.902 . . . . 0.0 108.442 179.427 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 3' ' ' TRP 0.307 20.4 tt -145.9 -80.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.432 ' H ' HG23 ' A' ' 2' ' ' ILE . 62.0 p-90 -65.22 -46.14 81.84 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.78 -87.02 0.08 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.97 171.89 12.57 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 123.024 0.529 . . . . 0.0 110.43 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t -72.21 -50.16 29.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.073 -1.642 . . . . 0.0 114.444 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.55 59.23 1.65 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 118.875 0.761 . . . . 0.0 114.442 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -160.45 -71.9 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.6 tp -148.02 -69.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.809 0.844 . . . . 0.0 108.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 103.31 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 122.173 0.987 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.2 p -147.31 100.71 3.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 124.115 1.912 . . . . 0.0 111.562 -179.59 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.456 HG23 ' H ' ' A' ' 3' ' ' TRP 0.292 20.1 tt -147.96 -77.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.456 ' H ' HG23 ' A' ' 2' ' ' ILE . 59.9 p-90 -61.27 -47.28 86.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.59 -103.09 0.17 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.85 148.02 27.96 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 t -70.58 -50.75 34.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.74 57.25 1.54 Allowed Glycine 0 N--CA 1.485 1.929 0 CA-C-N 119.179 0.899 . . . . 0.0 114.527 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -161.22 -69.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.8 tp -144.23 -67.96 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 0.0 109.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.32 106.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.661 0.784 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 122.306 1.05 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.6 p -96.52 83.61 3.54 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.639 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.153 1.93 . . . . 0.0 111.156 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.183 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.259 24.5 pt -97.14 -57.83 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 124.264 0.978 . . . . 0.0 111.729 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -77.51 -52.89 8.32 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.84 -93.55 1.91 Allowed Glycine 0 CA--C 1.541 1.702 0 CA-C-N 118.858 0.753 . . . . 0.0 112.702 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -146.27 171.51 14.86 Favored 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 123.458 0.703 . . . . 0.0 110.83 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.2 t -79.13 -58.88 3.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.488 -1.383 . . . . 0.0 114.023 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.76 65.95 1.24 Allowed Glycine 0 CA--C 1.544 1.905 0 CA-C-N 119.034 0.833 . . . . 0.0 113.999 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -157.92 -71.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.17 -77.57 0.45 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.0 tp -97.05 127.08 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.74 0.781 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.2 m -139.14 86.35 2.13 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 124.303 2.001 . . . . 0.0 110.168 -179.647 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.2 pt -99.38 -54.47 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 124.535 1.147 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -72.96 -51.39 18.6 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.25 -121.16 3.08 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 118.699 0.682 . . . . 0.0 112.333 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.62 161.63 14.84 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 122.868 0.467 . . . . 0.0 111.3 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.9 t -69.26 -50.36 47.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.4 56.22 2.44 Favored Glycine 0 CA--C 1.545 1.96 0 N-CA-C 115.128 0.811 . . . . 0.0 115.128 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -159.0 -69.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.661 0.784 . . . . 0.0 108.925 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.88 -74.38 0.31 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.0 tp -87.9 115.65 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 123.597 0.759 . . . . 0.0 109.281 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.957 0.884 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.3 m -154.62 104.53 2.55 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 124.216 1.96 . . . . 0.0 110.973 -179.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.221 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 23.1 pt -127.55 -43.61 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 124.478 1.111 . . . . 0.0 113.811 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -76.6 -58.03 3.52 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.63 -107.04 1.34 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.97 166.01 12.59 Favored 'General case' 0 CA--C 1.577 1.983 0 C-N-CA 122.818 0.447 . . . . 0.0 111.083 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -81.29 -67.81 0.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.523 -1.36 . . . . 0.0 112.454 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 136.46 -48.94 0.89 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -72.38 -59.58 2.66 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.2 tp -145.14 -71.43 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 119.248 0.931 . . . . 0.0 111.002 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.9 tp -78.91 104.64 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-N 119.042 0.837 . . . . 0.0 111.016 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 m -96.74 86.71 4.13 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 124.016 1.865 . . . . 0.0 110.66 -179.179 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.3 pt -127.77 -53.58 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 124.42 1.075 . . . . 0.0 112.052 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -82.32 -59.55 2.51 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 119.421 1.009 . . . . 0.0 113.056 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.97 -88.34 0.18 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -82.75 167.43 18.17 Favored 'General case' 0 CA--C 1.579 2.082 0 C-N-CA 122.835 0.454 . . . . 0.0 112.097 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 t -72.63 -52.74 14.12 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.25 57.32 2.02 Favored Glycine 0 CA--C 1.546 1.989 0 CA-C-N 118.948 0.795 . . . . 0.0 114.855 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -160.4 -69.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -142.26 -73.34 0.31 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -89.95 117.97 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.622 0.769 . . . . 0.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.866 0.841 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.5 m -96.3 83.52 3.59 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 124.373 2.035 . . . . 0.0 110.609 -179.678 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.274 17.1 pt -98.3 -66.89 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.165 0.915 . . . . 0.0 110.643 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -75.22 -55.74 5.42 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 119.317 0.962 . . . . 0.0 112.692 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.71 87.58 0.87 Allowed Glycine 0 N--CA 1.481 1.659 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -114.65 162.77 16.35 Favored 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 123.538 0.735 . . . . 0.0 111.679 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -77.72 -61.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.642 -1.286 . . . . 0.0 113.044 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.26 65.15 0.81 Allowed Glycine 0 N--CA 1.484 1.891 0 CA-C-N 119.074 0.852 . . . . 0.0 114.753 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -161.12 -73.11 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.8 tp -138.85 -73.04 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.7 tp -86.2 117.17 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.5 m -142.39 98.88 3.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 122.854 1.312 . . . . 0.0 109.746 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.4 pt -127.81 -53.52 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 124.248 0.968 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -84.02 -58.89 2.59 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.25 -87.77 0.99 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.69 158.92 44.48 Favored 'General case' 0 CA--C 1.575 1.937 0 C-N-CA 123.355 0.662 . . . . 0.0 109.735 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -74.78 -53.8 8.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.423 -1.423 . . . . 0.0 114.625 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.01 57.59 1.68 Allowed Glycine 0 CA--C 1.546 1.988 0 CA-C-N 119.037 0.835 . . . . 0.0 114.915 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -159.62 -75.78 0.07 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.4 mt -133.56 -73.05 0.49 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.4 tp -89.79 114.71 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.669 0.787 . . . . 0.0 109.353 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.571 1.776 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -145.51 80.33 1.59 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 124.378 2.037 . . . . 0.0 110.497 -179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.26 17.8 pt -82.06 -61.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 123.898 0.749 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -77.87 -51.66 10.09 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.712 0.805 . . . . 0.0 112.501 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.36 -88.48 0.07 OUTLIER Glycine 0 CA--C 1.537 1.424 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -149.39 156.49 42.12 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.358 0.663 . . . . 0.0 109.396 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.3 m -74.53 -52.11 12.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.405 -1.435 . . . . 0.0 114.778 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.6 55.68 2.0 Favored Glycine 0 CA--C 1.546 1.994 0 CA-C-N 119.037 0.835 . . . . 0.0 114.854 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -159.92 -75.01 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.3 mt -133.92 -71.93 0.5 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.3 tp -88.68 112.41 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 119.013 0.824 . . . . 0.0 109.82 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 6.3 t . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.7 m -96.51 85.65 3.95 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.157 1.932 . . . . 0.0 109.741 -179.453 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.79 -52.51 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 124.196 0.935 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -78.9 -53.68 6.82 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.776 0.83 . . . . 0.0 112.898 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.72 -100.8 0.14 Allowed Glycine 0 N--CA 1.479 1.521 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -139.13 159.47 42.07 Favored 'General case' 0 CA--C 1.576 1.962 0 C-N-CA 123.302 0.641 . . . . 0.0 110.193 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.2 m -78.13 -61.47 1.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.463 -1.398 . . . . 0.0 113.198 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.12 -46.06 1.1 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 115.816 1.087 . . . . 0.0 115.816 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -77.0 -65.53 0.94 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.9 mt -137.37 -69.08 0.46 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 119.38 0.991 . . . . 0.0 112.334 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 tp -79.62 99.15 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-N 119.361 0.982 . . . . 0.0 112.678 -178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 CA--C 1.579 2.082 0 N-CA-C 118.583 2.809 . . . . 0.0 118.583 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 82.5 m -125.29 84.59 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 124.251 1.977 . . . . 0.0 109.061 -178.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.18 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.25 47.4 pt -119.72 -47.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 124.286 0.991 . . . . 0.0 112.616 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.22 -57.79 3.64 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 119.382 0.992 . . . . 0.0 113.056 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.25 -91.49 0.08 OUTLIER Glycine 0 N--CA 1.479 1.53 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -145.68 160.87 41.06 Favored 'General case' 0 CA--C 1.577 1.991 0 C-N-CA 123.138 0.575 . . . . 0.0 110.365 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -73.1 -50.98 19.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.7 55.44 2.16 Favored Glycine 0 CA--C 1.545 1.951 0 N-CA-C 115.049 0.78 . . . . 0.0 115.049 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -160.16 -76.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.9 mt -134.75 -72.79 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.5 tp -86.87 113.58 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-N 118.945 0.793 . . . . 0.0 109.415 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 77.3 m -143.38 83.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 124.363 2.03 . . . . 0.0 110.111 -179.545 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 21.7 pt -119.02 -49.58 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 124.209 0.943 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -70.63 -57.19 4.97 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.394 0.997 . . . . 0.0 112.196 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.4 -95.19 0.76 Allowed Glycine 0 CA--C 1.543 1.793 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -160.32 156.99 27.19 Favored 'General case' 0 CA--C 1.576 1.944 0 CA-C-N 117.756 0.778 . . . . 0.0 111.159 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.8 m -81.57 -59.37 2.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.639 -1.288 . . . . 0.0 113.374 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.13 59.85 0.8 Allowed Glycine 0 CA--C 1.545 1.946 0 CA-C-N 118.99 0.814 . . . . 0.0 114.19 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -161.33 -70.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.4 tp -140.83 -72.86 0.35 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.9 tp -85.01 117.05 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 116.537 2.051 . . . . 0.0 116.537 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 m -152.16 109.8 3.62 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 124.13 1.919 . . . . 0.0 111.977 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.257 16.7 pt -140.68 -58.27 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 124.065 0.853 . . . . 0.0 111.097 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -90.39 -64.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.289 0.949 . . . . 0.0 112.218 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.07 -104.29 1.18 Allowed Glycine 0 N--CA 1.483 1.814 0 CA-C-N 119.097 0.862 . . . . 0.0 112.006 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -152.4 158.09 42.17 Favored 'General case' 0 CA--C 1.575 1.931 0 CA-C-N 117.314 0.557 . . . . 0.0 111.294 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -84.69 -61.62 1.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.155 . . . . 0.0 112.982 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.19 60.37 0.68 Allowed Glycine 0 CA--C 1.545 1.945 0 CA-C-N 119.201 0.909 . . . . 0.0 114.077 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -161.44 -70.89 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -138.62 -74.32 0.39 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.7 tp -85.61 116.53 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.256 6.0 t . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.8 m -147.0 83.5 1.58 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 124.109 1.909 . . . . 0.0 108.334 -179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.259 19.0 pt -130.72 -59.22 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 124.225 0.953 . . . . 0.0 110.966 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 20.8 t90 -84.2 -65.93 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 119.359 0.982 . . . . 0.0 111.641 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.66 -95.57 1.71 Allowed Glycine 0 N--CA 1.484 1.84 0 CA-C-N 118.985 0.811 . . . . 0.0 112.849 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.99 162.66 22.57 Favored 'General case' 0 CA--C 1.577 2.016 0 C-N-CA 122.919 0.488 . . . . 0.0 111.1 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.8 m -70.56 -47.83 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.26 50.09 4.44 Favored Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.975 0.75 . . . . 0.0 114.975 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.79 -75.12 0.08 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -134.75 -72.92 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.548 0.739 . . . . 0.0 109.239 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.7 tp -87.24 108.76 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-N 119.208 0.913 . . . . 0.0 110.204 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.252 6.6 t . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 119.088 2.996 . . . . 0.0 119.088 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.0 m -101.5 84.32 2.58 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 124.248 1.975 . . . . 0.0 109.972 -178.767 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -83.44 -56.39 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 124.013 0.821 . . . . 0.0 111.009 . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -65.45 -47.67 75.33 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.67 -97.24 0.14 Allowed Glycine 0 N--CA 1.478 1.489 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -141.08 155.21 46.17 Favored 'General case' 0 CA--C 1.574 1.873 0 C-N-CA 123.263 0.625 . . . . 0.0 109.627 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t -78.7 -64.51 1.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.53 -1.356 . . . . 0.0 113.292 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.23 -41.34 1.75 Allowed Glycine 0 CA--C 1.547 2.04 0 N-CA-C 116.217 1.247 . . . . 0.0 116.217 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -72.06 -54.89 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.2 tp -143.86 -77.06 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 119.44 1.018 . . . . 0.0 110.524 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -86.05 120.77 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 119.05 0.841 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 6.2 t . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 119.216 3.043 . . . . 0.0 119.216 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.1 m -100.88 88.66 3.61 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 124.02 1.867 . . . . 0.0 109.975 -178.416 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.182 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.304 0.0 OUTLIER -141.87 -71.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 124.132 0.895 . . . . 0.0 109.1 . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -80.21 -55.01 5.22 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.15 -92.73 1.77 Allowed Glycine 0 N--CA 1.481 1.646 0 CA-C-N 118.718 0.69 . . . . 0.0 112.499 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -148.41 166.08 29.18 Favored 'General case' 0 CA--C 1.578 2.022 0 C-N-CA 123.376 0.67 . . . . 0.0 110.766 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 t -73.01 -42.14 63.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.64 45.88 7.61 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 116.46 1.344 . . . . 0.0 116.46 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -145.52 -65.69 0.32 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.94 0.896 . . . . 0.0 108.751 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.7 tp -152.6 -69.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.0 106.24 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.5 m -106.34 79.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 124.108 1.909 . . . . 0.0 108.853 -179.657 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.258 22.8 pt -125.56 -57.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 124.271 0.982 . . . . 0.0 111.696 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -81.79 -61.56 1.89 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.56 1.073 . . . . 0.0 113.576 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.63 -91.9 1.77 Allowed Glycine 0 N--CA 1.483 1.773 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -154.33 157.16 38.2 Favored 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 123.264 0.626 . . . . 0.0 109.856 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -80.0 -58.96 2.91 Favored 'General case' 0 CA--C 1.564 1.499 0 O-C-N 120.611 -1.306 . . . . 0.0 114.111 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.7 57.66 1.09 Allowed Glycine 0 CA--C 1.546 2.028 0 CA-C-N 118.608 0.64 . . . . 0.0 113.785 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -159.6 -70.0 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.0 tp -139.79 -73.76 0.36 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.95 116.03 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.6 t . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 121.587 3.921 . . . . 0.0 121.587 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 t -151.59 93.44 1.87 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.461 1.028 . . . . 0.0 110.973 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 124.142 1.925 . . . . 0.0 109.067 179.157 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.232 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.256 21.6 pt -129.01 -57.07 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 124.252 0.97 . . . . 0.0 111.518 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 37.9 t-105 -82.51 -65.62 0.99 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 119.487 1.039 . . . . 0.0 112.828 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.45 -93.49 1.73 Allowed Glycine 0 CA--C 1.543 1.788 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -154.7 160.15 41.18 Favored 'General case' 0 CA--C 1.577 1.999 0 C-N-CA 123.436 0.694 . . . . 0.0 109.973 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 t -75.32 -50.73 15.1 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.08 53.04 2.92 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-N 118.888 0.767 . . . . 0.0 114.249 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -159.9 -68.76 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.904 0.882 . . . . 0.0 108.772 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.9 tp -141.99 -73.95 0.31 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.511 0.724 . . . . 0.0 109.451 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.69 109.74 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.263 5.6 t . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 121.425 3.861 . . . . 0.0 121.425 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.9 t -155.72 106.39 2.48 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 119.829 1.195 . . . . 0.0 110.249 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 124.091 1.9 . . . . 0.0 108.652 179.259 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.278 0.2 OUTLIER -130.75 -54.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 124.287 0.992 . . . . 0.0 111.933 . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -82.29 -63.59 1.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 119.812 1.187 . . . . 0.0 112.207 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.41 -94.33 1.7 Allowed Glycine 0 N--CA 1.482 1.706 0 CA-C-N 118.992 0.814 . . . . 0.0 113.459 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -83.55 163.58 20.32 Favored 'General case' 0 CA--C 1.577 2.019 0 C-N-CA 123.161 0.584 . . . . 0.0 111.964 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.9 t -70.58 -50.05 41.33 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.65 56.38 3.37 Favored Glycine 0 CA--C 1.546 2.004 0 CA-C-N 118.969 0.804 . . . . 0.0 114.71 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -158.9 -63.29 0.08 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.691 0.796 . . . . 0.0 109.729 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 10' ' ' ILE 0.299 0.4 OUTLIER -142.32 -74.02 0.3 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.638 0.775 . . . . 0.0 110.025 179.673 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.441 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -100.06 116.61 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.25 5.7 t . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 120.658 3.577 . . . . 0.0 120.658 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 t -144.32 109.22 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.132 1.92 . . . . 0.0 111.71 -179.858 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.268 0.2 OUTLIER -126.94 -50.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 124.329 1.018 . . . . 0.0 112.601 . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -77.82 -56.48 4.47 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 120.026 1.284 . . . . 0.0 114.105 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.12 -87.55 1.56 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.033 0.833 . . . . 0.0 112.153 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -144.2 165.07 28.88 Favored 'General case' 0 CA--C 1.576 1.966 0 C-N-CA 123.629 0.772 . . . . 0.0 110.162 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -75.37 -51.67 12.59 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.17 54.44 2.86 Favored Glycine 0 CA--C 1.547 2.087 0 CA-C-N 118.856 0.753 . . . . 0.0 114.173 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -159.69 -67.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.826 0.85 . . . . 0.0 109.208 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.28 2.4 pt? -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.567 0.747 . . . . 0.0 112.208 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.35 109.27 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.268 6.0 t . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 120.933 3.679 . . . . 0.0 120.933 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 t -152.91 108.28 3.26 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 119.525 1.057 . . . . 0.0 110.445 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 124.094 1.902 . . . . 0.0 108.442 179.427 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 3' ' ' TRP 0.307 20.4 tt -145.9 -80.68 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.432 ' H ' HG23 ' A' ' 2' ' ' ILE . 62.0 p-90 -65.22 -46.14 81.84 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.78 -87.02 0.08 OUTLIER Glycine 0 N--CA 1.478 1.456 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.97 171.89 12.57 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 123.024 0.529 . . . . 0.0 110.43 178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 t -72.21 -50.16 29.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.073 -1.642 . . . . 0.0 114.444 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.55 59.23 1.65 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 118.875 0.761 . . . . 0.0 114.442 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -160.45 -71.9 0.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.6 tp -148.02 -69.46 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.809 0.844 . . . . 0.0 108.759 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.88 103.31 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 122.173 0.987 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.2 p -147.31 100.71 3.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 124.115 1.912 . . . . 0.0 111.562 -179.59 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.167 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.456 HG23 ' H ' ' A' ' 3' ' ' TRP 0.292 20.1 tt -147.96 -77.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.456 ' H ' HG23 ' A' ' 2' ' ' ILE . 59.9 p-90 -61.27 -47.28 86.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.59 -103.09 0.17 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -150.85 148.02 27.96 Favored 'General case' 0 CA--C 1.57 1.718 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 t -70.58 -50.75 34.05 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.74 57.25 1.54 Allowed Glycine 0 N--CA 1.485 1.929 0 CA-C-N 119.179 0.899 . . . . 0.0 114.527 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -161.22 -69.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.8 tp -144.23 -67.96 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 0.0 109.224 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.32 106.03 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 123.661 0.784 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 122.306 1.05 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.6 p -96.52 83.61 3.54 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.639 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.153 1.93 . . . . 0.0 111.156 -179.662 . . . . . . . . 0 0 . 1 stop_ save_